AI assistant
Sending…
Edwards Lifesciences Corp — Director's Dealing 2021
May 11, 2021
30042_dirs_2021-05-11_a2e89f3e-f0d6-42cc-b0a5-7eca4c2c0801.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-05-07
Reporting Person: Ullem Scott B. (CVP, Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-07 | Common Stock | F | 538.0000 | $91.7500 | Disposed | 31676.0000 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 229251.0000 | Indirect |
More from Edwards Lifesciences Corp
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 27
Annual Report
2026
Feb 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 17